Net Profit Margin: 9.26%
Is the net profit margin high or low?
The net profit margin of 9.26% is 49% below its 5-year average of 18.14%, around the middle of its 5-year range (-0.31%–26.03%).
As of Saturday, June 27, 2026. 7.13% above its 12-month average of 8.64%.
NRC Profit Margin
Reported quarterly profit margin; no daily interpolation.
NRC Average Net Profit Margin Chart
NRC Current vs Average Net Profit Margin Chart
NRC Net Profit Margin Metrics
NET PROFIT MARGIN
9.26%
NET PROFIT MARGIN AVG TTM
8.64%
NET PROFIT MARGIN AVG 3Y
16.34%
NET PROFIT MARGIN AVG 5Y
20.39%
NET PROFIT MARGIN AVG 10Y
21.56%
NET PROFIT MARGIN AVG 15Y
19.74%
NET PROFIT MARGIN AVG 20Y
18.07%
CURRENT VS TTM AVG
+7.13%
CURRENT VS 3Y AVG
-43.34%
CURRENT VS 5Y AVG
-54.59%
CURRENT VS 10Y AVG
-57.06%
CURRENT VS 15Y AVG
-53.11%
CURRENT VS 20Y AVG
-48.77%
NRC Competitors' Net Profit Margin
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| National Research Corporation (NRC) | $468.99M | 9.26% | 8.64% | 16.34% | 20.39% |
| Shoulder Innovations, Inc. (SI)vs › | $472.62M | -81.78% | -67.34% | -66.78% | -66.78% |
| 23andMe Holding Co. (ME)vs › | $15.31M | -134.54% | -225.74% | -158.88% | -132.14% |
| Teladoc Health, Inc. (TDOC)vs › | $1.51B | -6.81% | -23.45% | -155.72% | -114.72% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.21B | -17.06% | -20.12% | -16.95% | -10.04% |
| TransMedics Group, Inc. (TMDX)vs › | $2.37B | 27.04% | 19.73% | -2.42% | -44.65% |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.57B | -0.56% | 7.00% | -0.29% | -8.82% |
| Oscar Health, Inc. (OSCR)vs › | $7.72B | -0.30% | -1.75% | -5.71% | -20.27% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.13B | 6.52% | -21.22% | -48.94% | 16.61% |
| Universal Health Services, Inc. (UHS)vs › | $9.12B | 8.56% | 7.89% | 6.46% | 6.98% |
Margin Comparison
Operating Margin
14.1%
Net Profit Margin
9.3%
Net Profit Margin Formula & Definition
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Net Profit Margin FAQ
- What is the net profit margin for National Research Corporation (NRC)?
- The net profit margin for NRC stock is 9.26%.
- Is National Research Corporation's net profit margin high or low?
- The net profit margin of 9.26% is 49% below its 5-year average of 18.14%, around the middle of its 5-year range (-0.31%–26.03%).
- What is the TTM average net profit margin for National Research Corporation (NRC)?
- The TTM average net profit margin for NRC stock is 8.64%.
- What is the 3Y average net profit margin for National Research Corporation (NRC)?
- The 3Y average net profit margin for NRC stock is 16.34%.
- What is the 5Y average net profit margin for National Research Corporation (NRC)?
- The 5Y average net profit margin for NRC stock is 20.39%.
- What is the 10Y average net profit margin for National Research Corporation (NRC)?
- The 10Y average net profit margin for NRC stock is 21.56%.
- What is the 15Y average net profit margin for National Research Corporation (NRC)?
- The 15Y average net profit margin for NRC stock is 19.74%.
- What is the 20Y average net profit margin for National Research Corporation (NRC)?
- The 20Y average net profit margin for NRC stock is 18.07%.
NRC Net Profit Margin History
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-03-31 | 9.26% |
| 2025-12-31 | 5.11% |
| 2025-09-30 | 11.91% |
| 2025-06-30 | -0.31% |
| 2025-03-31 | 17.25% |
| 2024-12-31 | 17.77% |
| 2024-09-30 | 15.88% |
| 2024-06-30 | 17.63% |
| 2024-03-31 | 18.01% |
| 2023-12-31 | 23.31% |
| 2023-09-30 | 20.76% |
| 2023-06-30 | 20.11% |
| 2023-03-31 | 19.09% |
| 2022-12-31 | 17.41% |
| 2022-09-30 | 22.01% |
| 2022-06-30 | 22.32% |
| 2022-03-31 | 22.21% |
| 2021-12-31 | 25.15% |
| 2021-09-30 | 25.57% |
| 2021-06-30 | 24.55% |
| 2021-03-31 | 26.03% |
| 2020-12-31 | 23.62% |
| 2020-09-30 | 28.61% |
| 2020-06-30 | 24.75% |
| 2020-03-31 | 34.72% |
| 2019-12-31 | 26.66% |
| 2019-09-30 | 24.93% |
| 2019-06-30 | 23.45% |
| 2019-03-31 | 25.95% |
| 2018-12-31 | 25.39% |
| 2018-09-30 | 23.22% |
| 2018-06-30 | 28.27% |
| 2018-03-31 | 23.46% |
| 2017-12-31 | 21.64% |
| 2017-09-30 | 14.24% |
| 2017-06-30 | 20.07% |
| 2017-03-31 | 21.36% |
| 2016-12-31 | 20.01% |
| 2016-09-30 | 17.34% |
| 2016-06-30 | 17.30% |
| 2016-03-31 | 19.59% |
| 2015-12-31 | 22.21% |
| 2015-09-30 | 16.28% |
| 2015-06-30 | 16.50% |
| 2015-03-31 | 13.16% |
| 2014-12-31 | 16.32% |
| 2014-09-30 | 19.22% |
| 2014-06-30 | 16.88% |
| 2014-03-31 | 20.95% |
| 2013-12-31 | 16.43% |
| 2013-09-30 | 17.02% |
| 2013-06-30 | 15.36% |
| 2013-03-31 | 17.95% |
| 2012-12-31 | 16.83% |
| 2012-09-30 | 16.73% |
| 2012-06-30 | 19.09% |
| 2012-03-31 | 17.18% |
| 2011-12-31 | 16.39% |
| 2011-09-30 | 14.27% |
| 2011-06-30 | 12.72% |
| 2011-03-31 | 17.46% |
| 2010-12-31 | 9.87% |
| 2010-09-30 | 13.38% |
| 2010-06-30 | 11.74% |
| 2010-03-31 | 18.01% |
| 2009-12-31 | 16.17% |
| 2009-09-30 | 14.75% |
| 2009-06-30 | 11.84% |
| 2009-03-31 | 15.83% |
| 2008-12-31 | 15.55% |
| 2008-09-30 | 14.59% |
| 2008-06-30 | 13.29% |
| 2008-03-31 | 14.89% |
| 2007-12-31 | 10.25% |
| 2007-09-30 | 17.89% |
| 2007-06-30 | 13.73% |
| 2007-03-31 | 13.06% |
| 2006-12-31 | 9.75% |
| 2006-09-30 | 17.59% |
| 2006-06-30 | 12.37% |
| 2006-03-31 | 12.84% |
| 2005-12-31 | 17.92% |
| 2005-09-30 | 20.03% |
| 2005-06-30 | 12.93% |
| 2005-03-31 | 11.34% |
| 2004-12-31 | 14.32% |
| 2004-09-30 | 18.42% |
| 2004-06-30 | 11.59% |
| 2004-03-31 | 15.54% |
| 2003-12-31 | 18.62% |
| 2003-09-30 | 16.27% |
| 2003-06-30 | 14.82% |
| 2003-03-31 | 15.20% |
| 2002-12-31 | 19.83% |
| 2002-09-30 | 19.50% |
| 2002-06-30 | 18.66% |
Related Metrics
About National Research Corporation
National Research Corporation (NRC) empowers healthcare organizations across the United States and Canada with data-driven analytics and actionable insights to enhance both patient and employee experiences. Through a comprehensive suite of subscription-based solutions, NRC supplies crucial information and analysis, addressing vital aspects such as the overall patient journey, service recovery initiatives, effective transitions of care, health risk assessments, fostering employee engagement, and enhancing reputation management and brand loyalty. Beyond these, NRC provides market intelligence to help organizations understand brand awareness, public perception, and competitive positioning. They offer advanced segmentation tools to analyze community needs, wants, and behaviors in real-time. Specialized health risk assessment tools are available to help clients pinpoint and support high-risk populations, fostering preventative care strategies and wellness initiatives. Similarly, transition management solutions assist in identifying and managing at-risk patients during care changes, aiming to reduce readmissions and ensure smooth, satisfactory transitions. NRC also offers transparency tools, empowering healthcare providers to present clear organizational information to consumers, thereby supporting informed decision-making. Furthermore, governance solutions are tailored for the leadership of non-profit hospitals and health systems, including boards of directors, executives, and physician leaders. Their clientele includes integrated health systems, post-acute care providers, and healthcare payer organizations. Established in 1981, National Research Corporation maintains its headquarters in Lincoln, Nebraska.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- CEO
- Trent Green